The Ministry of Health (Minsa) ordered the temporary closure of the Nordic Pharmaceutical Company SAC laboratory after the presence of the bacteria was detected. Ralstonia pickettii in a batch of medications used in critically ill patients.
The measure seeks to prevent new cases of infection linked to the contaminated product.
Through a statement released on social network X, the institution reported that the 100% of Edetoxin drug batch ABO25001after confirming its bacterial contamination.
According to the Minsa, the affected lot was made up of 24 thousand blistersof which more than 20 thousand (84%) They were recovered in the first 40 hours of the operation.
In the same publication, the ministry noted that 28 cases of infection were identifiedalthough There were no deaths associated with the product.. These infections were detected in patients who received the drug within hospital units.
He Vice Minister of Public Health, Ricardo Peñaassured that the situation is under control and clarified that the drug involved “It is not prescribed on an outpatient basis, but only in hospital units”.
Likewise, he highlighted the rapid action of the sector’s technical teams to contain the health risk and prevent further spread of the bacteria.
The Minsa reported that 100% of the ABO25001 batch of the Edetoxin drug has been immobilized and the Nordic Pharmaceutical Company SAC laboratory has been temporarily closed, after the presence of the Ralstonia pickettii bacteria was detected.
Of the 24,000 imported vials, it is already… pic.twitter.com/dYMNvMbKBK
— Ministry of Health (@Minsa_Peru) October 24, 2025
